NAPAMEZOLE
UNII GK4C2D295B

Substance Identification & Data

This profile provides standardized clinical and technical data for Napamezole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GK4C2D295B.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 91524-14-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

GK4C2D295B

CAS Registry Number

91524-14-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NAPAMEZOLE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C14H16N2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WETRBJOSGIDJHQ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C83985

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

55718

Unique identification number in the NCBI database of chemical substances.

INN ID

5695

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1=C(CC2=NCCN2)CCc3c1cccc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Napamezole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.